SCHEMBL22321982

SCHEMBL22321982

O=P(Cc1ccccc1)(Oc1ccc(I)cc1)Oc1ccc(I)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KLK8 O60259 2/20 0.51
PLAU P00749 2/20 0.51
KLK2 P20151 2/20 0.51
KLK4 Q9Y5K2 2/20 0.51
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
HTT P42858 1/20 0.42
APP P05067 2/20 0.42
LMNA P02545 1/20 0.41
MAPT P10636 1/20 0.41
HPGD P15428 1/20 0.40
SRC P12931 1/20 0.38
ANPEP P15144 1/20 0.38
LAP3 P28838 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
TDP1 Q9NUW8 1/20 0.37
RXRA P19793 1/20 0.36
RXRB P28702 1/20 0.36
TSHR P16473 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20710721 0.88 KLK8 (0.42) KLK8PLAUKLK2KLK4MEN1
SCHEMBL563232 0.87 KLK8 (0.63) KLK8PLAUKLK2KLK4MEN1
SCHEMBL22321983 0.83 SRC (0.44) KLK8PLAUKLK2KLK4MEN1
SCHEMBL22321984 0.82 LTA4H (0.53) KLK8PLAUKLK2KLK4MEN1
SCHEMBL28701098 0.77 KLK8 (0.57) KLK8PLAUKLK2KLK4HTT
SCHEMBL22322100 0.77 CA1 (0.54) KLK8PLAUKLK2KLK4MEN1
SCHEMBL17923914 0.76 KLK8 (0.53) KLK8PLAUKLK2KLK4MEN1
SCHEMBL4231397 0.75 KLK8 (0.59) KLK8PLAUKLK2KLK4MEN1
SCHEMBL916422 0.75 KLK8 (0.59) KLK8PLAUKLK2KLK4MEN1
SCHEMBL29267239 0.75 KLK8 (0.59) KLK8PLAUKLK2KLK4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10927135-B2 Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS (US) 2021-02-23 US disclosed
US-20200255461-A1 METAL-FREE DIRECT ARYLATION OF DIALKYL PHOSPHONATES FOR THE SYNTHESIS OF MIXED ALKYL ARYL PHOSPHONATES THE BOARD OF REGENTS OF THE NEVADA SYSTEM OF HIGHER EDUCATION ON BEHALF OF THE UNIVERSITY OF NEVADA, LAS VEGAS 2020-08-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200255461-A1 METAL-FREE DIRECT ARYLATION OF DIALKYL PHOSPHONATES FOR THE SYNTHESIS OF MIXED ALKYL ARYL PHOSPHONATES SLC35B2, PPIP5K2, PPA1 KLK8 2953/4885PLAU 4529/4885KLK2 1716/4885
US-10927135-B2 Metal-free direct arylation of dialkyl phosphonates for the synthesis of mixed alkyl aryl phosphonates SLC35B2, PPIP5K2, PPA1 KLK8 2953/4885PLAU 4529/4885KLK2 1716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.